Assessment of Assay for Rapid Identification of Bloodstream Infections

See also
Status	Clinical Trial	Phase
Completed	`NCT03894046` - Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex	Phase 3
Active, not recruiting	`NCT03354338` - Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy	Phase 2
Withdrawn	`NCT02543957` - Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
Completed	`NCT02210169` - RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates	N/A
Completed	`NCT01410578` - The Value of sTREM-1, PCT, and CRP as Markers for the Detection of Sepsis and Bacteremia Among Patients With a FUO	N/A
Terminated	`NCT00428051` - Colombia Epidemiologic Surveillance Study	N/A
Completed	`NCT00609375` - Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen	Phase 4
Terminated	`NCT00108433` - Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections	Phase 3
Completed	`NCT00177736` - Pharmacodynamic Parameters of Two Different Doses of Cefepime	Phase 4
Completed	`NCT00571259` - Prophylactic Antimicrobial Catheter Lock	Phase 4
Completed	`NCT00027248` - Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections	Phase 3
Completed	`NCT05585463` - Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021)
Recruiting	`NCT05950984` - Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)
Completed	`NCT03148769` - Spanish Bacteriemia Cohort 2016: Epidemiology, Clinical Management and Prognosis Factors
Completed	`NCT02536352` - Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being	Early Phase 1
Completed	`NCT02869191` - Blood Cultures's Profitability in Intensive Care Unit
Terminated	`NCT01734694` - Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients	Phase 4
Completed	`NCT01179022` - Incidence of Bacteremia Following Argon Plasma Coagulation in Patients With Endobronchial Lesions	N/A
Recruiting	`NCT00404625` - Infections Caused by ESbL-Producing Enterobacteriaceae in Italy	N/A
Completed	`NCT00398411` - Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells	Phase 3

NCT number	NCT04147975
Study type	Observational
Source	HelixBind, Inc.
Contact	Michael Reeve
Phone	508-460-1028
Email	mreeve@helixbind.com
Status	Recruiting
Phase
Start date	October 1, 2019
Completion date	October 30, 2020

Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms